Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

What Makes The Ideal Registry? Focus, Transparency, Versatility, Groups Say

This article was originally published in The Gray Sheet

Executive Summary

A report from Pew, the Blue Cross Blue Shield Association and Cornell researchers argues that a stronger system of medical device registries is needed in the U.S., but it also readily acknowledges the limits of registries and, in particular, the fact that they can be very resource intensive.

You may also be interested in...



AdvaMed Emphasizes Threshold Questions, Data Governance In Registry Principles

The trade group released revised data registry principles aimed at ensuring adequate data governance and containing “threshold questions” one should consider before implementing a registry as opposed to another form of information gathering.

Infuse Open-Access Project A Model For The Future? Medtronic Thinks So

Two independent analyses published last week on Medtronic’s Infuse biologic bone graft do not paint a positive picture for the device, but they do represent an important model for the future of open-access data analysis, both Medtronic and academic proponents say.

CDRH Details Path Forward For National Post-Market Surveillance System

The device center released an updated plan for post-market surveillance reforms, featuring a planning board that will establish a governing structure for the new system, as well as implementation dates for various post-market projects.

Topics

Latest News
See All
UsernamePublicRestriction

Register

MT033294

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel